The stock of the day is Imugene (IMU)
Imugene (IMU) - ASX Stock Analysis 12th January 2022
Mitch's top pick for high risk stock 2024 | ASX: IMU
Imugene (ASX: IMU) - Discussing IMU's 2022 Biotech Opportunity
ASX Stocks to Buy and Hold Forever: Your Ultimate Long-Term Investment
Top ASX Biotech Stocks for 2024
Why Novonix (NVX), Imugene (IMU) & Liontown (LTR) Share Price's Could Rise
Imugene (ASX: IMU) – New Global Partnership Announced For This Leading ASX Biotech
Imugene's HER-Vaxx Immunotherapy Treatment: Explained
Imugene (ASX: IMU) – The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈
How Imugene is Turning Viruses into Cancer-Fighting Heroes!
Imugene's CEO interviewed on ausbiz detailing a clinical trial deal with Merck Germany and Pfizer.
ASX CEO Connect March 2023 Imugene Limited (ASX: IMU)
3 TOP ASX Growth Stocks From 2021: Year In Review (BRN, LKE, IMU)
Stocks of the Hour: Imugene, RocketDNA, Marquee Resources
Imugene (ASX: IMU) – Partnership Announced With Pfizer & Merck
Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO
Why has The Star, Link, and Imugene requested a trading halt on ASX?
Stocks of the Hour: AML3D, Imugene, Loyal Lithium
Top 5 ASX Stocks Of The Day | ASX Small Cap Stocks (05/10/2021)